Heparin: An old drug for new clinical applications

P Wang, L Chi, Z Zhang, H Zhao, F Zhang… - Carbohydrate …, 2022 - Elsevier
Heparin, an old but first-line anticoagulant, has been used over a century. It is a
heterogeneous, linear, highly sulfated, anionic glycosaminoglycan with a broad distribution …

Antithrombotic therapy in patients with COVID-19?-Rationale and Evidence

C Godino, A Scotti, N Maugeri, N Mancini… - International journal of …, 2021 - Elsevier
In patients with severe or critical Coronavirus disease 2019 (COVID-19) manifestations, a
thromboinflammatory syndrome, with diffuse microvascular thrombosis, is increasingly …

Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the spike S1 receptor-binding domain with heparin

CJ Mycroft-West, D Su, I Pagani… - Thrombosis and …, 2020 - thieme-connect.com
The dependence of development and homeostasis in animals on the interaction of hundreds
of extracellular regulatory proteins with the peri-and extracellular glycosaminoglycan …

The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding

C Mycroft-West, D Su, S Elli, Y Li, S Guimond, G Miller… - BioRxiv, 2020 - biorxiv.org
Many pathogens take advantage of the dependence of the host on the interaction of
hundreds of extracellular proteins with the glycosaminoglycans heparan sulphate to …

Targeting heparin and heparan sulfate protein interactions

RJ Weiss, JD Esko, Y Tor - Organic & biomolecular chemistry, 2017 - pubs.rsc.org
Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides that are
made up of alternating dissacharide sequences of sulfated uronic acid and amino sugars …

Antivirals and the potential benefits of orally inhaled drug administration in COVID-19 treatment

G Sahin, O Akbal-Dagistan, M Culha, A Erturk… - Journal of …, 2022 - Elsevier
Abstract Coronavirus Disease 2019 (COVID-19) pandemic has been on the agenda of
humanity for more than 2 years. In the meantime, the pandemic has caused economic …

Molecular mechanism of the anti-inflammatory action of heparin

L Litov, P Petkov, M Rangelov, N Ilieva… - International Journal of …, 2021 - mdpi.com
Our objective is to reveal the molecular mechanism of the anti-inflammatory action of low-
molecular-weight heparin (LMWH) based on its influence on the activity of two key cytokines …

Pediatric adenovirus pneumonia: clinical practice and current treatment

J Zhang, Y Zhu, Y Zhou, F Gao, X Qiu, J Li… - Frontiers in …, 2023 - frontiersin.org
Adenovirus pneumonia is common in pediatric upper respiratory tract infection, which is
comparatively easy to develop into severe cases and has a high mortality rate with many …

Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells

S Ghezzi, L Cooper, A Rubio, I Pagani… - Antiviral research, 2017 - Elsevier
The recent Zika virus (ZIKV) outbreak, which mainly affected Brazil and neighbouring states,
demonstrated the paucity of information concerning the epidemiology of several flaviruses …

New applications of heparin and other glycosaminoglycans

M Lima, T Rudd, E Yates - Molecules, 2017 - mdpi.com
Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well
over half a century. Its introduction reduced clotting risks substantially and subsequent …